is topamax a glp-1 How Effective for Weight Loss? Topamax Lawsuit | Topamax Birth

Hildebrand, P

An option and weve done the studies and itll be indicated within our label is you can switch to an oral form

placebo INDIANAPOLIS, May 21, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the efficacy and safety of retatrutide, an investigational, first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, in adults with obesity or overweight and at least one weight-related comorbidity and without diabetes

Start with the standard tirzepatide dosing schedule and follow it as prescribed